Heparin, GORE VIABAHN VBX, BALLOON EXPANDABLE ENDOPROTHESIS, REF BXAL085902E, 8 MM X 59 MM 8 Fr, LARGE BALLOON EXPANDLBE, Nominal Stent Diameter 8 mm, Max Post-Dilated Stent Diameter 16 mm, UDI:
FDA Recall Z-0077-2022 · Posted None
Advertisement
Recalling FirmW L Gore & Associates, Inc.
Recall StatusOpen, Classified
Product CodePRL
Date Initiated2021-09-07
Product Quantity2 units
Reason for Recall
Incorrect labeling, specifically, expandable endoprosthesis labeled as 8 mm x 59mm x 135 cm, however may contain a 9mm x 29 mm x 135 cm device.
Firm Action
On September 9, 2021, Gore issued a "Urgent Field Safety Notice" to affected consignees via E-Mail. In addition to informing consignees about the recalled product, Gore asked consignees to take the following actions:
1. Identify and return the device listed in the CHANNEL PARTNER RESPONSE FORM if
unused.
2. Please complete and sign the enclosed CHANNEL PARTNER RESPONSE FORM and return
to [email protected] within 2 weeks of receipt of this notification.
3. Please share this letter with others in your hospital or clinic as appropriate.
4. If a listed device has been implanted, there is no patient-follow up needed and there are
no further actions needed other than informing Gore the device was used. Please
indicate the used device on the CHANNEL PARTNER RESPONSE FORM and return to
[email protected] within 2 weeks of receipt of this letter. No further action is
needed.
5. Any adverse event involving the GORE VIABAHN VBX Balloon Expandable
Endoprosthesis should be reported to the manufacturer and the country specific
regulatory authorities immediately. To report an event to W. L. Gore & Associates, email:
[email protected] or contact:
EMEA: +49 89 4612 3440, Fax: +49 89 4612 43440
6. This notice needs to be passed on to all those who need to be aware within your institution or to any organization where potentially affected devices have been transferred (as appropriate). Please transfer this notice to other organization(s) on which this action has an impact (as appropriate).
Root Cause
Component change control
Distribution Pattern
International distribution to the countries of Italy & Lebanon.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.
Advertisement